NEW: Find Out Why We're Different
Recently Registered: Yale University | Lexicon Pharmaceuticals | Protagonist Therapeutics | Flagship Pioneering
Novo Nordisk posts strong 2026 start and Wegovy pill surge: Wegovy pill surpasses 2 million prescriptions since January launch
Obesity has officially overtaken oncology as largest contributor to biopharma pipeline value for first time in deloitte’s industry analysis, underscoring commercial momentum behind next-generation weight-loss therapies
Eli Lilly doubles down on its obesity franchise with a $4.5 billion expansion across its Indian manufacturing network

Register by Friday, June 12 to Save up to $400

Day

Hour

Minute

Second

The Future of Cardiovascular-Kidney-Metabolic (CKM)- Direct to Participant Trials

The Future of Cardiovascular-Kidney-Metabolic (CKM)- Direct to Participant Trials

By | 19 May 2026

We must bring trials to the patient rather than the patient to the trials.
We must democratize access to the trials.